As rigorous clinical trials continue to unfold, the foundational role of GlyNAC in repairing endothelial damage, supporting exhausted immune function, and restoring cellular energy remains a primary focal point of chronic illness research and recovery strategies
Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes
S., Ye, S.-H., Birch, L., Ho, S.-M
Clinical trials by Novo Nordisk, maker of Wegovy and Ozempic, found that hair loss can affect up to one in 10 patients
Efinopegdutide has been granted fast track designation by the FDA for the treatment of MASH (NCT04944992, NCT05877547) and this is the indication that the clinical development programme of this molecule will focus